Patents by Inventor José Manuel Soria
José Manuel Soria has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20230093652Abstract: The present inventors provide miRNAs useful in the diagnosis and prediction, with high accuracy, of the risk of a subject to suffering from a thrombosis condition. The present invention also provides a method for deciding or recommending initiating a medical anti-thrombotic therapy.Type: ApplicationFiled: March 2, 2021Publication date: March 23, 2023Inventors: Jose Manuel Soria Fernandez, Alba Rodriguez Rius, Juan Carlos Souto Andres
-
Publication number: 20220380849Abstract: The invention relates to a method for a more appropriate thromboembolic event risk assessment based on the presence of different genetic variant. The invention also relates to a method for determining the risk of suffering a thromboembolism disease by combining the absence or presence of one or more polymorphic markers in a sample from the subject with conventional risk factors for thromboembolism as well as computer-implemented means for carrying out said method.Type: ApplicationFiled: May 25, 2021Publication date: December 1, 2022Applicant: Genincode UK, Ltd.Inventors: Matthew Heaton Walls, Marta Carrera, José Manuel Soria, Roberto Elosua Llanos
-
Publication number: 20220372572Abstract: The invention relates to a method for a more appropriate risk assessment for the possible occurrence of a pregnancy loss or recurrent pregnancy loss, based on the presence of different genetic variants. The invention also relates to a method for determining the risk of suffering a a pregnancy loss or RPL by combining the absence or presence several polymorphic markers in a sample from the subject with conventional risk factors as well as computer-implemented means for carrying out said method.Type: ApplicationFiled: February 8, 2019Publication date: November 24, 2022Inventors: Eduardo Salas, José Antonio Páramo, Sara Pich, Jose Bellver, Kevin Guillén, Israel Ortega, José Manuel Soria
-
Publication number: 20210130893Abstract: The present invention is directed to in vitro methods for determining the fitness of a subject based on the determination of the expression levels of different genes. The invention also provides an in vitro method for selecting a subject as having a fitness level suitable to participate in an endurance sport, for monitoring the response to training of a subject during an endurance exercise training and for selecting a personalized training program aimed at improving fitness of a subject, based on the determination of the expression levels of said genes, as well as a kit comprising reagents for determining said expression levels and the use thereof, a computer program and a computer-implemented method.Type: ApplicationFiled: November 26, 2018Publication date: May 6, 2021Applicants: UNIVERSITAT POLITECNICA DE CATALUNYA, FUNDACIO INSTITUT DE RECERCA DE L'HOSPITAL DE LA SANTA CREU I SANT PAU, SUMMIT 2014, S.L.Inventors: Alexandre PERERA LLUNA, Maria MAQUEDA GONZALEZ, Emma ROCA RODRIGUEZ, Jose Manuel SORIA FERNANDEZ
-
Patent number: 10557170Abstract: The invention relates to a method for a more appropriate thromboembolic event risk assessment based on the presence of different genetic variant. The invention also relates to a method for determining the risk of suffering a thromboembolism disease by combining the absence or presence of one or more polymorphic markers in a sample from the subject with conventional risk factors for thromboembolism as well as computer-implemented means for carrying out said method.Type: GrantFiled: July 17, 2017Date of Patent: February 11, 2020Assignee: Gendiag.exe, S.L.Inventors: Eduardo Salas, José Manuel Soria, Miroslava Ogorelkova, Roberto Elosua Llanos, Joan Vila, Sergio Castillo Fernandez
-
Patent number: 10023914Abstract: The invention relates to a method for a more appropriate thromboembolic event risk assessment based on the presence of different genetic variant. The invention also relates to a method for determining the risk of suffering a thromboembolism disease by combining the absence or presence of one or more polymorphic markers in a sample from the subject with conventional risk factors for thromboembolism as well as computer-implemented means for carrying out said method.Type: GrantFiled: October 19, 2015Date of Patent: July 17, 2018Assignee: Gendiag.exe, S.L.Inventors: Eduardo Salas, José Manuel Soria, Miroslava Ogorelkova, Roberto Elosua, Joan S. Vila, Sergio Castillo
-
Publication number: 20180066313Abstract: The invention relates to a method for a more appropriate thromboembolic event risk assessment based on the presence of different genetic variant. The invention also relates to a method for determining the risk of suffering a thromboembolism disease by combining the absence or presence of one or more polymorphic markers in a sample from the subject with conventional risk factors for thromboembolism as well as computer-implemented means for carrying out said method.Type: ApplicationFiled: July 17, 2017Publication date: March 8, 2018Applicant: Gendiag.exe, S.L.Inventors: Eduardo Salas, José Manuel Soria, Miroslava Ogorelkova, Roberto Elosua Llanos, Joan Vila, Sergio Castillo Fernandez
-
Patent number: 9518297Abstract: The invention relates to a method for a more appropriate thromboembolic event risk assessment based on the presence of different genetic variant. The invention also relates to a method for determining the risk of suffering a thromboembolism disease by combining the absence or presence of one or more polymorphic markers in a sample from the subject with conventional risk factors for thromboembolism as well as computer-implemented means for carrying out said method.Type: GrantFiled: June 13, 2012Date of Patent: December 13, 2016Assignee: Gendiag.exe, S.L.Inventors: Eduardo Salas, José Manuel Soria, Miroslava Ogorelkova, Roberto Elosua Llanos, Joan Vila, Sergio Castillo
-
Publication number: 20160102355Abstract: The invention relates to a method for a more appropriate thromboembolic event risk assessment based on the presence of different genetic variant. The invention also relates to a method for determining the risk of suffering a thromboembolism disease by combining the absence or presence of one or more polymorphic markers in a sample from the subject with conventional risk factors for thromboembolism as well as computer-implemented means for carrying out said method.Type: ApplicationFiled: October 19, 2015Publication date: April 14, 2016Applicant: Gendiag.exe, S.L.Inventors: Eduardo Salas, José Manuel Soria, Miroslava Ogorelkova, Roberto Elosua Llanos, Joan Vila, Sergio Castillo Fernandez
-
Publication number: 20140221230Abstract: The invention relates to a method for a more appropriate thromboembolic event risk assessment based on the presence of different genetic variant. The invention also relates to a method for determining the risk of suffering a thromboembolism disease by combining the absence or presence of one or more polymorphic markers in a sample from the subject with conventional risk factors for thromboembolism as well as computer-implemented means for carrying out said method.Type: ApplicationFiled: June 13, 2012Publication date: August 7, 2014Applicant: Gendiag.exe, S.L.Inventors: Eduardo Salas, José Manuel Soria, Miroslava Ogorelkova, Roberto Elosua Llanos, Joan Vila, Sergio Castillo